Continent’s top firms drove most of European equity gains last year
GSK
Euronext Dublin finished the day down 0.3% as it was dragged lower by homebuilders and hotels group Dalata
British drug maker’s first annual earnings report after spinning off Haleon in July 2022
Pharma giant GSK, whose predecessor companies profited from the trials, has so far resisted calls to contribute
British medicines group and US rival Pfizer have both committed to selling down stakes over time to fund core pharma operations
Shoppers choosing to buy less has spooked large groups but costs unlikely to drop even as inflation moderates
Maker of Marmite and Magnums latest to signal easing of inflationary pressures
Bank shares edge backwards while Glanbia and Irish Continental rise
Drugmaker’s Xevudy fails to tackle most prevalent variants of coronavirus, say US regulators
Kate Ferry to replace Julie Brown who heads to GSK
Drug giant rang up worldwide sales of more than £29 billion last year. Its refusal to contribute a cent to State’s redress scheme is inexcusable
Questions remain about hospitalisation and side effects but drugmaker stays step ahead of British group GSK which faces similar panel
YOU MAY ALSO LIKE...
How does a post-Brexit world shape the identity and relationship of these islands
Inquests into the nightclub fire that led to the deaths of 48 people
Weddings, Births, Deaths and other family notices